AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

NCT04499248 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: AGN-193408 SR
OTHER: Lumigan
OTHER: Sham Administration
OTHER: Lumigan Vehicle
DRUG: AGN-193408 SR
OTHER: Sham Administration
OTHER: Lumigan Vehicle

Sponsor

AbbVie